Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 79 results for "yeda research development company"

TxCell gets CAR-Treg patent through exclusive option agreement...

TxCell SA, a biotechnology company developing innovative, personalised T cell immunotherapies using regulatory T-cells for severe chronic inflammatory and autoimmune diseases, has entered into an exclusive option agreement with Yeda Research and ... PharmaBiz, 3 weeks ago

CELL SOURCE, INC. FILES (8-K) Disclosing Other Events

ITEM 8.01 OTHER EVENTS On November 4, 2015 Cell Source, Inc. (OTCQB: CLCS) a biotechnology company focused on developing cell therapy treatments based on immunotherapy and regenerative medicine, announced their initiative for joint venture Pharma ...
 Pharmacy Choice3 weeks ago CELL SOURCE : Other Events (form 8-K)  4 Traders3 weeks ago Cell Source, Inc. (CLCS: OTCQB) | Inaugural Scientific Advisory Board Summit JV Pharma Collaboration Initiative  OTC Markets3 weeks ago Inaugural Scientific Advisory Board Summit JV Pharma Collaboration Initiative  RCL Advisors3 weeks ago

Research and Markets: Global Infectious Diagnostics Rapid & Point of Care Tests Pipeline Review 2015

Research and Markets ( has announced the addition of the "Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Review, 2015" report to their offering. Research and Markets ( ...
 MoneyShow.com22 hours ago RESEARCH AND MARKETS : Global Infectious Diagnostics Rapid & Point of Care Tests Pipeline Review 2015  4 Traders22 hours ago

Innovation: What it means for WA

ShareShare on FacebookShare on TwitterShare on Google+Share on RedditEmail a friend THERE is an exciting energy in Perth regarding our innovation sector and tech start-ups — businesses using high leverage on labour to develop digital technology ... days ago
Bidness Etc

Why Teva Pharmaceutical Industries Ltd (ADR) Popped In Trade Yesterday

Teva Pharmaceutical Industries Ltd. (ADR) ( NYSE:TEVA ) gained nearly 1.10% in trade yesterday after Goldman Sachs upgraded the stock from Neutral to Buy. The 12-month price target for the world's largest generic drug-maker was maintained at $75 ...
 Bidness Etc4 days ago
Seeking Alpha

Premarket Biotech Digest: Democrats Debate Biotech, Anavex Rally, Johnson & Johnson Results

Summary Democrats consider biotech industry as one of their enemies. Wait for a further pullback to enter Anavex. Johnson & Johnson beats on earnings, misses on revenue. (This digest has multiple sections, a few of which are shown ...
 Seeking Alpha1 month ago

ENZ Settles Suit With AFFX, PTLA On Fast Track, XTLB Given Enough Time

Enzo Biochem Inc. (ENZ) has reached a $10 million settlement with Affymetrix Inc. (AFFX) in a patent infringement suit related to technology for nucleic acid analysis. The settlement with Affymetrix impacts only one of 11 cases originally brought ...
 RTTNews.com1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less